XML 15 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Cover Page - shares
6 Months Ended
Jun. 30, 2025
Jul. 31, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2025  
Document Transition Report false  
Entity File Number 001-37722  
Entity Registrant Name SPYRE THERAPEUTICS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-4312787  
Entity Address, Address Line One 221 Crescent Street  
Entity Address, Address Line Two Building 23  
Entity Address, Address Line Three Suite 105  
Entity Address, City or Town Waltham  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02453  
City Area Code 617  
Local Phone Number 651-5940  
Title of 12(b) Security Common Stock, $0.0001 Par Value Per Share  
Trading Symbol SYRE  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   60,400,960
Entity Central Index Key 0001636282  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2